Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

VTX958 for the Treatment of Moderately to Severely Active Crohn's Disease

ClinicalTrials.gov ID: NCT05688852

Public ClinicalTrials.gov record NCT05688852. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 4:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VTX958 in Participants With Moderately to Severely Active Crohn's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, randomized, double-blind placebo-controlled, parallel group study to evaluate the efficacy and safety of VTX958 in participants with moderately to severely active Crohn's Disease.

Study identification

NCT ID
NCT05688852
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ventyx Biosciences, Inc
Industry
Enrollment
107 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 25, 2023 (Actual)
Primary completion
Jun 27, 2024 (Actual)
Completion
Dec 20, 2024 (Actual)
Last update posted
Jul 3, 2025

2023 – 2024

United States locations

U.S. sites
26
U.S. states
15
U.S. cities
24
Facility City State ZIP Site status
Local Site # 840105 Garden Grove California 92845 —
Local Site # 840109 Lancaster California 93534 —
Local Site # 840124 Kissimmee Florida 34744 —
Local Site # 840104 Miami Florida 33165 —
Local Site # 840108 Orlando Florida 32806 —
Local Site # 840125 Orlando Florida 32825 —
Local Site # 840112 Atlanta Georgia 30342 —
Local Site # 840115 Glenview Illinois 60026 —
Local Site # 840107 Gurnee Illinois 60031 —
Local Site # 840119 New Albany Indiana 47150 —
Local Site # 840127 Louisville Kentucky 40218 —
Local Site # 840113 Shreveport Louisiana 71105 —
Local Site # 840117 Chevy Chase Maryland 20815 —
Local Site # 840118 Rockville Maryland 20850 —
Local Site # 840116 Liberty Missouri 64068 —
Local Site # 840121 Winston-Salem North Carolina 27103 —
Local Site # 840122 Columbus Ohio 43202 —
Local Site # 840106 Oklahoma City Oklahoma 73102 —
Local Site # 840123 Myrtle Beach South Carolina 29572 —
Local Site # 840111 Garland Texas 75044 —
Local Site # 840103 Katy Texas 77484 —
Local Site # 840110 Lubbock Texas 79410 —
Local Site # 840114 Lubbock Texas 79424 —
Local Site # 840102 Southlake Texas 76092 —
Local Site # 840101 Tyler Texas 75701 —
Local Site # 840126 West Jordan Utah 84088 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 79 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05688852, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 3, 2025 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05688852 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →